ADHD combo drug trial stops early – only 2 teens enrolled
NCT ID NCT06673368
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial tested a combination of two drugs, NRCT-101SR and NRCT-202XR, for teens with ADHD. The goal was to see if the combo could ease symptoms and reduce side effects better than one drug alone. However, the study was terminated early and only enrolled 2 participants, so no meaningful results were obtained.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NRCT-101SR and NRCT-202XR (drug combination)
What this could lead to
If it had succeeded, this could have pointed toward a new combination treatment for ADHD that reduces side effects.
What could go wrong
The trial was terminated early with only 2 participants, so no conclusions can be drawn. It is very early-stage and uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADHD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accel Research Site-Maitland Clinical Research Unit
Maitland, Florida, 32751, United States
-
Boston Clinical Trials LLC
Boston, Massachusetts, 02131, United States
-
CenExel iRS - iResearch Savannah
Savannah, Georgia, 31405, United States
-
Center For Psychiatry and Behavioral Medicine
Las Vegas, Nevada, 89128, United States
-
iResearch Atlanta
Decatur, Georgia, 30030, United States